Tuesday, November 10, 2015
- 4:30PM-6:00PM
-
Abstract Number: 6L
Effect of Interleukin-17A Inhibition on Spinal Radiographic Changes through 2 Years in Patients with Active Ankylosing Spondylitis: Results of a Phase 3 Study with Secukinumab
ACR Late-breaking Abstract Session- 4:30PM-6:00PM
-
Abstract Number: 3219
Efficacy and Safety of 4 Weeks Administration of Arsenic Trioxide in Moderate Active Systemic Lupus Erythematosus. a Phase I/II Proof-of-Concept Sequential Dose Escalation Multicenter Study
Systemic Lupus Erythematosus - Clinical Aspects and Treatment VI: Novel Therapies- 4:30PM-6:00PM
-
Abstract Number: 4L
Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials
ACR Late-breaking Abstract Session- 4:30PM-6:00PM
-
Abstract Number: 3189
Enhancement of Mitochondrial Biogenesis Inhibits Cell Proliferation and MMP-3/RANKL Secretion in Rheumatoid Arthritis Fibroblast-like Synovial Cells and Joint Destruction in Arthritis Model Mice
Rheumatoid Arthritis Animal Models II- 4:30PM-6:00PM
-
Abstract Number: 3166
Epistatic Interaction of Functional Inflammasome Genetic Variants in Determining the Risk of Gout
Metabolic and Crystal Arthropathies II: Mechanisms and Associations- 4:30PM-6:00PM
-
Abstract Number: 3210
Evaluation of Sacroiliac Joint Radiographs in Patients with Chronic Low Back Pain: Is Erosion the Main Driver of Interreader Disagreement?
Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Clinical Aspects, Imaging and Biomarkers- 4:30PM-6:00PM
-
Abstract Number: 3235
Factors Associated with Nonadherence to Recently Initiated Disease-Modifying Antirheumatic Drugs
ARHP IV: Clinical Practice and Patient Care- 4:30PM-6:00PM
-
Abstract Number: 3186
Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes
Rheumatoid Arthritis - Clinical Aspects V: Goal = Remission- 4:30PM-6:00PM
-
Abstract Number: 3202
Functional Anti-Muscarinic Receptor-3 Monoclonal Antibodies Derived from Salivary Gland in Patients of Sjögren’s Syndrome
Sjögren's Syndrome II: Clinical Discoveries- 4:30PM-6:00PM
-
Abstract Number: 3182
High Body Mass Index Negatively Impacts Time to Achieving Sustained Remission in Early Rheumatoid Arthritis: Results from a Multicenter Early Arthritis Cohort Study
Rheumatoid Arthritis - Clinical Aspects V: Goal = Remission- 4:30PM-6:00PM
-
Abstract Number: 3181
How Common Is Inactive Disease in a Prospective Cohort of Patients with Juvenile Idiopathic Arthritis? the Importance of Definition
Pediatric Rheumatology - Clinical and Therapeutic Aspects IV: Imaging and Novel Clinical Interventions- 4:30PM-6:00PM
-
Abstract Number: 3168
How Strong Cardiovascular Risk Factor Are Gouty Tophi?
Metabolic and Crystal Arthropathies II: Mechanisms and Associations- 4:30PM-6:00PM
-
Abstract Number: 3204
Hypoechoic Lesions on Parotid Gland Ultrasound Are a Surrogate Marker of Focal Lymphocytic Sialadenitis on Minor Salivary Gland Biopsy in Sjögren’s Syndrome
Sjögren's Syndrome II: Clinical Discoveries- 4:30PM-6:00PM
-
Abstract Number: 3227
Identification of Novel Protein-Coding Genetic Variants Associated with Takayasu Arteritis